Emergent Biosolutions Inc (EBS)

Other Income/Expenses (Net)

-$41.20M

Quarterly · Period ending: · USD

EBS logo

EBS Other Income/Expenses (Net)

Latest reported-$41.20M
EBS Quarterly Other Income/Expenses (Net) (-$6.10M → -$41.20M)
High-resolution chart · PNG

EBS other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-41,200,000
2,900,000
-34,100,000
-19,200,000
-17,300,000
44,100,000
-18,100,000
77,900,000
-66,300,000
-27,700,000
-10,700,000
-23,799,999
42,700,000
-13,000,000
-6,100,000
-21,900,000
-10,800,000
-10,200,000
-9,900,000
-10,800,000
-7,300,000
-10,200,000
-5,300,000
-6,300,000
-5,300,000
-9,700,000
-6,200,000
-11,800,000
-8,100,000
-10,600,000
-7,700,000
200,000
-1,000,000
100,000
-1,172,000
-1,455,000
-1,808,000
-1,265,000
-1,807,000
-1,925,000
-1,267,000
-1,303,000
-2,003,000
-1,012,000
-1,304,000
-1,479,000
-312,000
-1,331,000
-368,000
-2,983,000
365,000
146,000
25,000
29,000
3,255,000
39,000
936,000
876,000
-228,000
59,000
-21,000
34,000
19,000
-965,000
380,000
375,000
372,000
428,000
289,000
272,000
603,000
11,291,000
650,000
650,000
839,000
451,000
579,000
1,025,000
69,000
11,378,000
-21,948,000
-21,948,000
38,989,000
-28,967,000
-28,967,000
-28,967,000
49,669,000
-20,874,000
-20,874,000
-20,874,000
-6,100,000
-10,800,000
42,700,000
-10,200,000
-6,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.